| Line 35: | 
Line 35: | 
|   | * [https://canadiantaskforce.ca/wp-content/uploads/2016/12/procedural-manual-en_2014_Archived.pdf Canadian Task Force on Preventive Healthcare disclosure of interest form] (see Appendix 1)  |   | * [https://canadiantaskforce.ca/wp-content/uploads/2016/12/procedural-manual-en_2014_Archived.pdf Canadian Task Force on Preventive Healthcare disclosure of interest form] (see Appendix 1)  | 
|   | * [https://community.cochrane.org/sites/default/files/uploads/EPPR/Cochrane-COI-disclosure-form.pdf Cochrane Collaboration disclosure of interest form]  |   | * [https://community.cochrane.org/sites/default/files/uploads/EPPR/Cochrane-COI-disclosure-form.pdf Cochrane Collaboration disclosure of interest form]  | 
| − | * US FDA financial disclosure report – Executive Branch  | + | * [https://www.uspto.gov/sites/default/files/documents/OGE450_June_2015.pdf US FDA financial disclosure report – Executive Branch]  | 
| − | * US FDA financial disclosure report – Special Government Employees  | + | * [https://www.fda.gov/media/70455/download US FDA financial disclosure report – Special Government Employees]  | 
| − | * National Academies of Science Engineering and Medicine disclosure of interest form for general scientific and technical studies and assistance  | + | * [https://www.nationalacademies.org/coi/bi-coi_form-3.pdf National Academies of Science Engineering and Medicine disclosure of interest form for general scientific and technical studies and assistance]  | 
| − | * National Academies of Science Engineering and Medicine disclosure of interest form for studies involving program reviews and evaluations  | + | * [https://www.nationalacademies.org/coi/bi-coi_form-2.pdf National Academies of Science Engineering and Medicine disclosure of interest form for studies involving program reviews and evaluations]  | 
| − | * National Academies of Science Engineering and Medicine disclosure of interest form for studies related to government regulation  | + | * [https://www.nationalacademies.org/coi/bi-coi_form-1.pdf National Academies of Science Engineering and Medicine disclosure of interest form for studies related to government regulation]  | 
|   | * National immunization technical advisory groups (NITAGs)  |   | * National immunization technical advisory groups (NITAGs)  | 
| − | ** Initial COI declaration form  | + | ** [http://www.nitag-resource.org/uploads/media/default/0001/04/e80de42a64ee6f017cc42996b34a0cbb6e056ff0.pdf Initial COI declaration form]  | 
| − | ** COI annual update form  | + | ** [http://www.nitag-resource.org/uploads/media/default/0001/04/e80de42a64ee6f017cc42996b34a0cbb6e056ff0.pdf COI annual update form]  | 
| − | ** COI declaration prior to a meeting  | + | ** [http://www.nitag-resource.org/uploads/media/default/0001/04/e80de42a64ee6f017cc42996b34a0cbb6e056ff0.pdf COI declaration prior to a meeting]  | 
|   |  |   |  | 
| − | * National Institute for Health and Care Excellence (UK) disclosure of interest form for advisory committees  | + | * [https://www.nice.org.uk/Media/Default/About/Who-we-are/Policies-and-procedures/declaration-form.docx National Institute for Health and Care Excellence (UK) disclosure of interest form for advisory committees]  | 
| − | * National Institute of Health and Care Excellence (UK) disclosure of interest form for board members and employees  | + | * [https://www.nice.org.uk/Media/Default/About/Who-we-are/Policies-and-procedures/declaring-and-managing-interests-board-and-employees.pdf National Institute of Health and Care Excellence (UK) disclosure of interest form for board members and employees]  | 
| − | * Scottish Intercollegiate Guideline Network (SIGN) disclosure of interest form for completion by individuals, carers, voluntary organisations and members of the public  | + | * [https://www.sign.ac.uk/assets/delirium_pat_doi_form.pdf Scottish Intercollegiate Guideline Network (SIGN) disclosure of interest form for completion by individuals, carers, voluntary organisations and members of the public]  | 
| − | * United States Preventive Services Task Force (USPSTF) disclosure of interest form  | + | * [https://www.uspreventiveservicestaskforce.org/Page/Name/appendix-ii-uspstf-conflict-of-interest-disclosure-form United States Preventive Services Task Force (USPSTF) disclosure of interest form]  | 
|   | + |    | 
|   | + | === Examples of published summaries of disclosures ===  | 
|   | + | * Australian Technical Advisory Group on Immunisation disclosure summary  | 
|   | + | * Haute Authorité de Santé (France) examples of public disclosures of experts  | 
|   | + |    | 
|   | + | === Examples of scales for assessing the significance of COI ===  | 
|   | + | * American Thoracic Society method for evaluating significance of COI  | 
|   | + | * World Health Organization criteria for assessing the severity of a conflict of interest (see p. 78)  | 
|   | + | * USPSTF COI significance and management table  | 
|   |  |   |  | 
|   | === Examples of algorithms/process maps for COI management ===  |   | === Examples of algorithms/process maps for COI management ===  | 
| − | * American Thoracic Society COI resolution procedure  | + | * [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i14 American Thoracic Society COI resolution procedure]  | 
|   | * CADTH pan-Canadian Oncology Drug Review COI management overview (Appendix A)  |   | * CADTH pan-Canadian Oncology Drug Review COI management overview (Appendix A)  | 
|   | * European Medicines Agency COI management matrix  |   | * European Medicines Agency COI management matrix  | 
| Line 57: | 
Line 66: | 
|   | * National Research Council Canada COI flowchart  |   | * National Research Council Canada COI flowchart  | 
|   | * National Institute of Health and Care Excellence (UK) process for declaring interests (Appendix A)  |   | * National Institute of Health and Care Excellence (UK) process for declaring interests (Appendix A)  | 
| − | 
  |   | 
| − | === Examples of published summaries of disclosures ===
  |   | 
| − | o  Australian Technical Advisory Group on Immunisation disclosure summary
  |   | 
| − | 
  |   | 
| − | o  Haute Authorité de Santé (France) examples of public disclosures of experts
  |   | 
| − | 
  |   | 
| − | === Examples of scales for assessing the significance of COI ===
  |   | 
| − | o  American Thoracic Society method for evaluating significance of COI
  |   | 
| − | 
  |   | 
| − | o  World Health Organization criteria for assessing the severity of a conflict of interest (see p. 78)
  |   | 
| − | 
  |   | 
| − | o  USPSTF COI significance and management table
  |   | 
|   |  |   |  | 
|   | === [https://annals.org/aim/fullarticle/2450219/guidelines-international-network-principles-disclosure-interests-management-conflicts-guidelines GIN principles paper] ===  |   | === [https://annals.org/aim/fullarticle/2450219/guidelines-international-network-principles-disclosure-interests-management-conflicts-guidelines GIN principles paper] ===  |